ScholarLens Back to search
2023•Unpublished venueOpen access

Supplemental Tables S1-S4 from An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy

Richard Tavaré, Helena Escuin-Ordinas, Stephen Mok, Melissa McCracken, Kirstin A. Zettlitz, Felix B. Salazar, Owen N. Witte, Antoni Ribas, Anna M. Wu

Open full text 0 citations

Abstract

Supplemental Tables S1-S4: Ex vivo biodistribution of 89Zr-malDFO-169 cDb in wt and CD8-blocked ARK mice (S1); Ex vivo biodistribution of 89Zr-malDFO-169 cDb in the adoptive T cell transfer model (S2); Ex vivo biodistribution of 89Zr-malDFO-169 cDb in the anti-CD137/CT26 immunotherapy model (S3); 89Zr-malDFO-169 cDb ex vivo biodistribution analysis at 22 h post-injection of anti-PD-L1 partial responding (S4).

Open-access reader

About this research paper

What this paper is about

Supplemental Tables S1-S4: Ex vivo biodistribution of 89Zr-malDFO-169 cDb in wt and CD8-blocked ARK mice (S1); Ex vivo biodistribution of 89Zr-malDFO-169 cDb in the adoptive T cell transfer model (S2); Ex vivo biodistribution of 89Zr-malDFO-169 cDb in the anti-CD137/CT26 immunotherapy model (S3); 89Zr-malDFO-169 cDb ex vivo biodistribution analysis at 22 h post-injection of anti-PD-L1 partial responding (S4).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Supplemental Tables S1-S4: Ex vivo biodistribution of 89Zr-malDFO-169 cDb in wt and CD8-blocked ARK mice (S1); Ex vivo biodistribution of 89Zr-malDFO-169 cDb in the adoptive T cell transfer model (S2); Ex vivo biodistribution of 89Zr-malDFO-169 cDb in the anti-CD137/CT26 immunotherapy model (S3); 89Zr-malDFO-169 cDb ex vivo biodistribution analysis at 22 h post-injection of anti-PD-L1 partial responding (S4).

Key concepts: Biodistribution, Ex vivo, In vivo, Immunotherapy, CD8, Adoptive cell transfer, Adoptive immunotherapy, Chemistry

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Supplemental Tables S1-S4 from An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy — Research Paper | ScholarLens